Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivasha nanosilver spray and sildenafil ointment for wound healing after suppurative appendicitis
IRCT20191104045328N50Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sildenafil in Wound infection (WI) and Suppurative appendicitis, sponsored by Arak University of Medical Sciences. Started Jan 2026; status: completed.
02
Drugs
sildenafil
03
Conditions
Wound infection (WI)Suppurative appendicitis
Beyond the preview
Go deeper on IRCT20191104045328N50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N50.